V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16628236 | 330007255 | EK1PP | 1.8 | null | 1 | 2014-01-28 | NOT CHEMO | 330008427 | 330004060 | 330007257 |
| 16628237 | 330007255 | ERA20 | 140 | X721 | 1 | 2014-01-29 | DOCETAXEL | 330008427 | 330004060 | 330007257 |
| 16628238 | 330007255 | ERA20 | 300 | X721 | 5 | 2014-01-29 | NOT CHEMO | 330008427 | 330004060 | 330007257 |
| 16628239 | 330007256 | EK1EN | 0 | null | 2 | 2017-02-19 | CYCLOPHOSPHAMIDE | 330008439 | 330004061 | 330007258 |
| 16628240 | 330007256 | EUZ | 2 | X729 | 1 | 2017-02-19 | TRIAL | 330008439 | 330004061 | 330007258 |
| 16628241 | 330007257 | EOI | 1760 | null | 1 | 2018-01-25 | AVELUMAB | 330008443 | 330004062 | 330007259 |
| 16628242 | 330007258 | EEI00 | 1760 | null | 1 | 2017-05-20 | NOT CHEMO | 330008443 | 330008213 | 330007260 |
| 16628243 | 330007258 | E0N03 | 150 | X721 | 1 | 2017-05-20 | TRIAL | 330008443 | 330008213 | 330007260 |
| 16628244 | 330007260 | ERA20 | 562.5 | null | 1 | 2016-12-08 | AVELUMAB | 330008466 | 330004064 | 330007262 |
| 16628245 | 330007260 | E1UZ0 | 3840 | null | 1 | 2016-12-08 | AVELUMAB | 330008466 | 330004064 | 330007262 |
| 16628263 | 330007267 | EON | 2720 | X729 | 1 | 2014-01-15 | NOT CHEMO | 330008562 | 330004069 | 330007269 |
| 16628264 | 330007267 | EEI00 | 210 | null | 2 | 2014-01-16 | VINCRISTINE | 330008562 | 330004069 | 330007269 |
| 16628265 | 330007267 | EEI00 | 1.6 | X724 | 1 | 2014-01-16 | DACTINOMYCIN | 330008562 | 330004069 | 330007269 |
| 16628266 | 330007267 | EUZ | 5600 | N/A | 1 | 2014-01-16 | IFOSFAMIDE | 330008562 | 330004069 | 330007269 |
| 16628267 | 330007267 | EGQ01 | 150 | X729 | null | 2014-01-16 | DACTINOMYCIN | 330008562 | 330004069 | 330007269 |
| 16628268 | 330007267 | ERA20 | 31 | X724 | 1 | 2014-01-20 | CISPLATIN | 330008562 | 330004069 | 330007269 |
| 16628269 | 330007267 | EN201 | 0 | X724 | 0 | 2014-01-20 | NOT CHEMO | 330008562 | 330004069 | 330007269 |
| 16628270 | 330007267 | ENW | 1800 | X721 | 1 | 2014-01-20 | FLUOROURACIL | 330008562 | 330004069 | 330007269 |
| 16628271 | 330007267 | EAF01 | 8 | X724 | 1 | 2014-01-20 | NOT CHEMO | 330008562 | 330004069 | 330007269 |
| 16628272 | 330007268 | EC4 | 2400 | X721 | 1 | 2017-08-02 | TOPOTECAN | 330008566 | 330004070 | 330007270 |
| 16628273 | 330007268 | E1UZ0 | 4000 | X724 | 1 | 2017-08-03 | TRIAL | 330008566 | 330004070 | 330007270 |
| 16628274 | 330007270 | EEI00 | 200 | X721 | 1 | 2017-01-11 | STEROID | 330008567 | 330004075 | 330007272 |
| 16628275 | 330007271 | EEI00 | 1780 | X721 | 1 | 2016-04-04 | ETOPOSIDE | 330008567 | 330004075 | 330007273 |
| 16628276 | 330007271 | EXO | 1 | X292 | 2 | 2016-04-04 | STEROID | 330008567 | 330004075 | 330007273 |
| 16628277 | 330007271 | EGU02 | 4100 | null | 1 | 2016-04-04 | MESNA | 330008567 | 330004075 | 330007273 |
| 16628278 | 330007272 | EPH | 1800 | X729 | 1 | 2015-07-25 | MULTIPLE | 330008586 | 330004076 | 330007274 |
| 16628279 | 330007273 | EPH | 210 | null | 2 | 2017-04-18 | NAB-PACLITAXEL | 330008592 | 330004078 | 330007275 |
| 16628280 | 330007273 | EE813 | 0 | x724 | 1 | 2017-04-19 | STEROID | 330008592 | 330004078 | 330007275 |
| 16628281 | 330007273 | EEI00 | 330 | X721 | 1 | 2017-04-20 | DOXORUBICIN | 330008592 | 330004078 | 330007275 |
| 16628282 | 330007273 | EK1EN | 1450 | null | 1 | 2017-04-21 | IFOSFAMIDE | 330008592 | 330004078 | 330007275 |
| 16628283 | 330007273 | ED301 | 27 | X728 | 1 | 2017-04-21 | ETOPOSIDE | 330008592 | 330004078 | 330007275 |
| 16628284 | 330007273 | ELW | 1650 | null | 1 | 2017-04-22 | FLUOROURACIL | 330008592 | 330004078 | 330007275 |
| 16628285 | 330007274 | EPH | 1800 | X724 | 1 | 2016-02-19 | CYCLOPHOSPHAMIDE | 330008594 | 330004079 | 330007276 |
| 16628286 | 330007274 | EOF | 0 | null | 1 | 2016-02-19 | NOT MATCHED | 330008594 | 330004079 | 330007276 |
| 16628287 | 330007274 | EEI00 | 0 | X721 | 1 | 2016-02-19 | VINCRISTINE | 330008594 | 330004079 | 330007276 |
| 16628288 | 330007275 | EE813 | 1800 | null | 2 | 2017-05-05 | PEMBROLIZUMAB | 330008603 | 330004080 | 330007277 |
| 16628289 | 330007276 | EK1EN | 100 | X729 | null | 2015-08-11 | ETOPOSIDE | 330008603 | 330004081 | 330007278 |
| 16628290 | 330007276 | ECL01 | 2 | X724 | null | 2015-08-12 | TRIAL | 330008603 | 330004081 | 330007278 |
| 16628291 | 330007276 | ED301 | 200 | X721 | 1 | 2015-08-13 | ETOPOSIDE | 330008603 | 330004081 | 330007278 |
| 16628292 | 330007276 | EE813 | 39 | X724 | 1 | 2015-08-14 | CYCLOPHOSPHAMIDE | 330008603 | 330004081 | 330007278 |
| 16628293 | 330007276 | EEI00 | 2 | X729 | 1 | 2015-08-14 | VINCRISTINE | 330008603 | 330004081 | 330007278 |
| 16628294 | 330007276 | ERS12 | 60 | X721 | 1 | 2015-08-14 | DOCETAXEL | 330008603 | 330004081 | 330007278 |
| 16628295 | 330007276 | EUDJC | 1900 | X721 | 1 | 2015-08-14 | FLUOROURACIL | 330008603 | 330004081 | 330007278 |
| 16628296 | 330007276 | EXO | 4 | X721 | 2 | 2015-08-14 | STEROID | 330008603 | 330004081 | 330007278 |
| 16628297 | 330007277 | ECL01 | 100 | X729 | 1 | 2018-01-27 | TOPOTECAN | 330008614 | 330012395 | 330007279 |
| 16628298 | 330007277 | ECL01 | 170 | null | 1 | 2018-01-27 | CETUXIMAB | 330008614 | 330012395 | 330007279 |
| 16628302 | 330007286 | E1UZ0 | 100 | X721 | 2 | 2018-04-23 | CYCLOPHOSPHAMIDE | 330008707 | 330004088 | 330007288 |
| 16628303 | 330007286 | ELW | 0.5 | X729 | 1 | 2018-04-23 | CYCLOPHOSPHAMIDE | 330008707 | 330004088 | 330007288 |
| 16628304 | 330007287 | EEI00 | 1100 | x724 | 1 | 2016-01-19 | TRIAL | 330008719 | 330010462 | 330007289 |
| 16628305 | 330007287 | EEI00 | 38 | X721 | 1 | 2016-01-26 | ETOPOSIDE | 330008719 | 330010462 | 330007289 |